What is the recommended dosage and usage of Rizatriptan (Maxalt) for acute migraine treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rizatriptan (Maxalt) Dosage and Usage for Acute Migraine Treatment

The recommended starting dose of rizatriptan for acute migraine treatment in adults is either 5 mg or 10 mg, with the 10 mg dose providing greater efficacy but potentially more side effects. The maximum daily dose should not exceed 30 mg in any 24-hour period. 1

Adult Dosing Guidelines

  • Initial dose: 5 mg or 10 mg orally at migraine onset 1
  • Redosing: If migraine returns, a second dose may be administered 2 hours after the first dose 1
  • Maximum daily dose: 30 mg in any 24-hour period 1
  • Dosing interval: Can be taken every two hours as needed, not exceeding maximum daily dose 2, 3
  • The 10 mg dose is generally more effective than the 5 mg dose for pain relief 1, 4

Special Dosing Considerations

Patients Taking Propranolol

  • Adults on propranolol: Only 5 mg dose is recommended, up to maximum of 3 doses in 24 hours (15 mg total) 1
  • Pediatric patients ≥40 kg on propranolol: Only a single 5 mg dose (maximum 5 mg in 24 hours) 1
  • Not recommended for propranolol-treated pediatric patients weighing <40 kg 1

Pediatric Patients (Age 6-17 years)

  • Patients <40 kg (88 lb): 5 mg dose 1
  • Patients ≥40 kg (88 lb): 10 mg dose 1
  • Multiple dosing within 24 hours has not been established as safe in pediatric patients 1

Administration Options

  • Standard oral tablets 1
  • Orally disintegrating tablets (Maxalt MLT) - beneficial when nausea/vomiting are present 2

Treatment Approach

  • Try rizatriptan for 2-3 migraine episodes before determining effectiveness 2, 3
  • If one triptan is ineffective, try a different triptan 2, 3
  • For moderate to severe migraines or mild to moderate migraines that respond poorly to NSAIDs, triptans like rizatriptan are recommended 2

Safety Considerations

Contraindications

  • Concurrent use with ergotamine derivatives 2
  • Use within 24 hours of another triptan 2
  • Hemiplegic or basilar migraine 2
  • Coronary artery disease 2
  • MAOIs (monoamine oxidase inhibitors) 2
  • Impaired hepatic function 2
  • Pregnancy 2

Common Side Effects

  • Dizziness, drowsiness, and asthenia/fatigue (typically mild to moderate and short-lasting) 5, 4
  • Chest pressure and heaviness 2
  • Throat tightness 2
  • Nausea 4

Clinical Efficacy

  • Rizatriptan provides rapid onset of action with pain relief beginning as early as 30 minutes after dosing 6
  • At 2 hours post-dose, up to 77% of patients taking rizatriptan 10 mg experience pain relief compared to 37% with placebo 7
  • Up to 44% of patients are completely pain-free at 2 hours compared to 7% with placebo 7

Important Monitoring

  • The safety of treating more than four headaches in a 30-day period has not been established 1
  • Monitor for overuse, which may lead to rebound headaches 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Maximum Recommended Dose of Rizatriptan

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Rizatriptan: a new 5-HT1B/1D receptor agonist for the treatment of migraine.

Expert opinion on investigational drugs, 1999

Research

Rizatriptan in the treatment of migraine.

Clinical therapeutics, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.